ORIGINAL RESEARCH article
Front. Sens.
Sec. Biosensors
Toward A Modular Label-Free Electrochemical Biosensing Platform Based on a One-Pot Avidin Functionalization of Reduced Graphene Oxide
- DF
Daiana Fernanda Reartes 1,2
- GA
Gustavo Adolfo Rivas 2,1
- MD
Maria Dolores Rubianes 1,2
- MC
Marcela Cecilia Rodríguez 1,2
1. Instituto de Investigaciones en Fisicoquimca de Cordoba, Córdoba, Argentina
2. Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
A one-pot, ultrasound-assisted and environmentally responsible strategy is proposed for the simultaneous partial reduction and biofunctionalization of graphene oxide (GO), using L-tyrosine (L-tyr) and ascorbic acid (AA) as mild and complementary reducing agents. This synergistic approach enables controlled partial restoration of the sp2 carbon framework while preserving oxygen functionalities required for biomolecular anchoring. Avidin is incorporated in situ during the reduction process, eliminating post-synthetic modification steps while enabling its functional role in biotinylated recognition element immobilization. The resulting avidin-functionalized reduced graphene oxide (rGO) provides a functional electrochemical interface for the oriented immobilization of biotinylated recognition elements through the avidin-biotin affinity interaction. This immobilization strategy was conceived to facilitate the assembly of different biosensing interfaces without requiring surface re-engineering. The platform was implemented as a label-free electrochemical interface and characterized by electrochemical impedance spectroscopy to monitor interfacial assembly and biorecognition events. As a proof-of-concept, the proposed immobilization strategy was experimentally validated using the thrombin-binding aptamer as a representative biotinylated recognition element for the detection of human α-thrombin (α-th). The platform exhibited a linear response from 1.34 x 10-9 M to 2.67 x 10-6 M (R2 = 0.987) and detection limit of 4.4 x 10-10 M, demonstrating selective response in the presence of potentially interfering proteins and enriched human serum samples. These results demonstrate a sustainable one-pot strategy for producing avidin-functionalized rGO and establish a proof-of-concept for an avidin-based electrochemical biointerface. Although the present study experimentally validates the approach using a single aptamer-target pair, the proposed immobilization strategy may enable the future development of adaptable electrochemical biosensing platforms employing different biotinylated recognition elements without modifying the underlying transducer
Summary
Keywords
Avidin-biotin interaction, Human α-thrombin, Label-free electrochemical sensing, Modular biosensing platform, One-pot biofunctionalization, Reduced graphene oxide
Received
24 April 2026
Accepted
02 September 2026
Copyright
© 2026 Reartes, Rivas, Rubianes and Rodríguez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Maria Dolores Rubianes; Marcela Cecilia Rodríguez
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.